secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0000950170-22-011072
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

RxSight stockholders re-elect three Class I directors and ratify EY as auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Ron Kurtz, J. Andy Corley, and Juliet Tammenoms Bakker re-elected as Class I directors with over 18.3M votes for each.
- Ernst & Young LLP ratified as independent auditor for FY2022 with 22,575,352 votes for, 2,827 against, 118,118 abstain.
- Approximately 82.6% of outstanding shares (22.7M of 27.5M) were represented at the virtual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022011072/0000950170-22-011072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022011072/rxst-20220602.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer